okddy88
()



تاریخ ثبت نام: 1401/8/16
تاریخ تولد: تعیین نشده
زمان محلی: 2022/12/01 , 09:18 PM
وضعیت: آفلاین

اطلاعات انجمن okddy88
تاریخ عضویت: 1401/8/16
آخرین بازدید: 1401/8/16 ، 05:18 صبح
کل ارسال‌ها: 0 (0 ارسال در هر روز | 0 درصد از کل ارسال‌ها)
(یافتن تمامی ارسال‌ها)
کل موضوع‌ها: 0 (0 موضوع در هر روز | 0 درصد از کل موضوع‌ها)
(یافتن تمامی موضوع‌ها)
مدت زمان حضور در انجمن: 3 دقیقه, 34 ثانیه
اعتبار: 0 [جزییات]

اطلاعات تماسِ okddy88
وب‌ سایت: http://www.senwayerpeptide.com/peptide/
ایمیل: ارسال یک ایمیل به okddy88.
پیام خصوصی: ارسال یک پیام خصوصی به okddy88.
  
اطلاعات اضافی درباره‌ی okddy88
جنسیت: مرد
مدرک: دانشجو
مهارتهای تخصصی: Peptides (from Ancient Greek πεπτός (peptós) 'digested', from πέσσειν (péssein) 'to digest') are short chains of amino acids linked by peptide bonds. Chains of fewer than twenty amino acids are called oligopeptides, and include dipeptides, tripeptides , and tetrapeptides. A polypeptide is a longer, continuous, unbranched peptide chain. Hence, peptides fall under the broad chemical classes of biological polymers and oligomers, alongside nucleic acids, oligosaccharides, polysaccharides, and others. A polypeptide that contains more than approximately fifty amino acids is known as a protein. Proteins consist of one or more polypeptides arranged in a biologically functional way, often bound to ligands such as coenzymes and cofactors, or to another protein or other macromolecule such as DNA or RNA, or to complex macromolecular assemblies. Amino acids that have been incorporated into peptides are termed residues. A water molecule is released during formation of each amide bond. All peptides except cyclic peptides have an N-terminal (amine group) and C-terminal (carboxyl group) residue at the end of the peptide (as shown for the tetrapeptide in the image).

Selective Androgen Receptor Modulators or SARMs are a class of androgen receptor ligands that maintain some of the desirable effects of androgens, such as preventing osteoporsis and muscle loss while reducing risks of developing prostate cancer. In the last 1990s, the first nonsteroidal SARM, an analog of bicalutamide, was discovered. They are intended to have the same kind of effects as androgenic drugs, such as anabolic-androgenic steroids, but be more selective in their action. As of early 2020, there are no SARMs which have been approved for therapeutic use by the U.S Food and Drug Administration.